UPDATE 3-Amgen expects strong demand for new migraine prevention drug

April 24 (Reuters) - Amgen Inc on Tuesday reported a higher first-quarter profit, as sales rose 3 percent - a trend it expects to accelerate as it launches new drugs like migraine treatment Aimovig, likely to get U.S. approval next month.